Atherosclerotic plaque injury-mediated murine thrombosis models: advantages and limitations

M. F. A. Karel, B. Hechler, M. J. E. Kuijpers, J. M. E. M. Cosemans*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In spite of current treatment strategies, myocardial infarction and stroke are still major causes of death worldwide. These events are triggered by damage of an atherosclerotic plaque, resulting in occlusive thrombus formation. Mouse studies have significantly contributed to our understanding of the mechanisms of atherogenesis and of thrombosis following plaque injury, but the extent to which the mouse serves as an accurate model of human disease is open to discussion. In this review, we provide a detailed overview and comparison of the described mouse models for atherothrombosis including their (dis)advantages. Herein guidance is provided on how to select a suitable atherothrombosis model for research questions primarily relevant to the field of thrombosis.

Original languageEnglish
Pages (from-to)439-446
Number of pages8
JournalPlatelets
Volume31
Issue number4
DOIs
Publication statusPublished - 19 Jan 2020

Keywords

  • Atherosclerosis
  • coagulation
  • murine atherothrombosis
  • plaque erosion
  • plaque rupture
  • platelets
  • PLATELET GLYCOPROTEIN-VI
  • FACTOR PATHWAY INHIBITOR
  • PLASMINOGEN-ACTIVATOR
  • HEART-DISEASE
  • MICE
  • MECHANISMS
  • EXPRESSION
  • ATHEROTHROMBOSIS
  • DESTABILIZATION
  • PROGRESSION

Cite this